Wednesday, April 7, 2010 as of 11:14 AM ET
Synthes Holding AG (formerly Synthes-Stratec) is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States.
Read More at Wikipedia ›NEW BRUNSWICK, N.
J. -(Dow Jones)- Alex Gorsky, Johnson & Johnson's (JNJ) incoming chief executive, said his No. 1 priority was fixing the problems in the company's over-the-counter medicine business, which has been hurt by recalls that have dimmed sales and damaged the health-care giant's reputation.Mr. Gorsky, who takes the helm of J&J from William Weldon on Thursday, voiced confidence that the health-care giant has taken the steps needed to revive the business and reintroduce withdrawn products while upgrading manufacturing."No. 1, we've got to get product on the shelves, and I'm very confident our teams can rebuild a lot of these brands," Mr. Gorsky said in an interview Wednesday.Starting in late 2009, J&J began recalling iconic medicines like children's Tylenol after finding metal shavings were found in some bottles, as well as excessive concentrations of active ingredients and bad odors. Earlier this year, the company was forced to recall some Tylenol that it had put back on store...Johnson & Johnson's (JNJ) incoming CEO is viewed as having the experience and skills to lead the company out of a difficult period, but he's unlikely to change J&J's...
Synthes Inc. (SYST.VX) Thursday reported a 6.5% increase in full-year earnings ahead of its planned merger with Johnson & Johnson (JNJ) later this year.MAIN FACTS:- ...
Hopes the advent of former Nestle SA (NESN.VX) manager Richard Laube as Chief Executive of Nobel Biocare Holding AG would translate into a quick rebound of the denta...
Johnson & Johnson (JNJ) reported an 89% drop in fourth-quarter profit due to legal settlements and product-liability costs, while the health-care giant avoided a thi...
FOX Business: The Power to ProsperThe markets rallied for a second-straight day after the Federal Reserve said it plans on keeping short-term interest rates at extra...
FOX Business: The Power to ProsperThe markets rallied for a second-straight day after the Federal Reserve said it plans on keeping short-term interest rates at extra...
Johnson & Johnson (NYSE:JNJ) snatched up Swiss medical devices maker Synthes on Wednesday in a cash-and-stock deal worth $21.3 billion.The transaction marks New Brun...
Bangalore (Reuters) - U.S. healthcare conglomerate Johnson & Johnson is expected to announce a $21.5 billion deal to buy Swiss medical device maker Synthes Inc on We...
By Katie ReidZURICH (Reuters) - Flying fanatic Hansjoerg Wyss, chairman of Swiss medical device maker Synthes <SYST.VX>, has navigated his group into the flight path...
European shares dropped to a three-week low in morning trade on Monday on nervousness ahead of quarterly earnings results and lingering worries about indebted euro z...
LONDON -- Synthes Inc. confirmed on Monday it's in talks with Johnson & Johnson about a potential business combination. "No assurance can be given as to whether, whe...
By Katie ReidZURICH (Reuters) - Synthes <SYST.VX> said on Monday it was in takeover talks with Johnson & Johnson <JNJ.N>, after reports the U.S. group is looking to ...
The European Commission cleared Thursday the acquisition of Synthes Inc. (SYST.VX), an orthopaedic medical devices company, by Johnson & Johnson (JNJ).The competitio...
Johnson & Johnson (JNJ) Tuesday reported a slight decline in first-quarter sales because of drug patent expirations and manufacturing constraints, but the company po...
("Johnson & Johnson 1Q Profit Rose 12% On Forex Gain, Lower Costs," published at 8:36 a.m. EDT, misstated the change in revenue in the fifth paragraph. A corrected v...
DOW JONES NEWSWIRESBiomet Inc. has made a binding offer to acquire the global trauma business of Johnson & Johnson's (JNJ) DePuy Orthopaedics Inc. for about $280 mil...
Synthes Inc. (SYST.VX) Tuesday said it and Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial co...
DOW JONES NEWSWIRESJohnson & Johnson (JNJ) is set to receive European Union approval for its $21.3 billion purchase of Swiss medical device company Synthes Inc. (SYS...
Synthes Inc. (SYST.VX) received a warning letter from federal regulators last month regarding complaint procedures at its facility in West Chester, Pa.The letter, is...
